Skip to content
zameds

Myoprin

Aspirin

Loading the molecular structure
C9H8O4180.16 g/mol

2-Acetyloxybenzoic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2244.

Registration

Applicants
1
Registrations
1

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Ipharma (Pty) LtdMyoprin100 mgB1117Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Myoprin 100 MG

EACH TABLET CONTAINS ASPIRIN 100 mg

100 mgB1117B/2.7/1117RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S2: Aspirin

    • the treatment of children or adolescents; and
    • the prophylaxis of cardiovascular disease in adults (S0)

    Consolidated Schedules 06 July 2026, lines 1616 to 1620

5 of 7 approved products with this ingredient carry S3 on their leaflet.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsMyoprin 100 MG, Ipharma (Pty) Ltd. SAHPRA's document for MyoprinPatient information leaflet (PIL)For patients and carersMyoprin 100 MG, Ipharma (Pty) Ltd. SAHPRA's document for Myoprin

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles